Agency information collection activities; proposals, submissions, and approvals,

[Federal Register: August 17, 2004 (Volume 69, Number 158)]

[Notices]

[Page 51095]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr17au04-63]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2004N-0026]

Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishments Registration and Listing

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

SUMMARY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishments Registration and Listing'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of Management Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of May 27, 2004 (69 FR 30315), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0469. The approval expires on July 31, 2007. A copy of the supporting statement for this information collection is available on the Internet at http://www.fda.gov/ohrms/dockets.

Dated: August 6, 2004. Jeffrey Shuren, Assistant Commissioner for Policy.

[FR Doc. 04-18723 Filed 8-16-04; 8:45 am]

BILLING CODE 4160-01-S

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT